Rep. James Comer

Maddy summaryThe American Enrichment Deployment Act modifies federal rules to allow the construction of uranium enrichment facilities to begin before a full operating license is granted. This change applies to companies building these facilities, permitting them to start construction under the same conditions used for other nuclear fuel cycle projects. The Nuclear Regulatory Commission must update its regulations within 180 days to implement these new procedures while retaining its authority to oversee safety and enforce compliance.

Repealing Big Brother Overreach Act This bill repeals the Corporate Transparency Act. The act requires existing companies and newly created companies to report beneficial ownership information to the Department of the Treasury’s Financial Crimes Enforcement Network for purposes of addressing the financing of terrorism and money laundering.

Maddy summaryThis bill, known as the Stopping Harmful and Outrageous Torts Act, expands legal protections for firearm manufacturers and sellers by strengthening their immunity from civil lawsuits. It requires courts to immediately dismiss any pending cases against these companies that are based on the criminal or unlawful misuse of a gun by a third party, while also clarifying that sellers are not liable for negligence in entrusting products to others. The legislation further restricts who can file such suits by prohibiting foreign governments from bringing these claims and adding a specific exception for victims under the age of 17, though it maintains immunity for cases involving design or manufacturing defects. Additionally, the bill allows companies to move these cases to federal court and grants them the right to appeal dismissal orders immediately, along with the ability to recover legal fees if they win. Finally, it preempts state and local laws that attempt to impose liability on these entities for the same types of misuse-related harms.

Maddy summaryThe Stopping Fraudulent Payments Act directs federal agencies to temporarily delay, condition, or split payments when there is a high risk of fraud or if a recipient is flagged in the Do Not Pay system. Under this law, agencies must notify payees of any pauses, explain the specific risk indicators involved, and allow recipients to contest the decision within a set timeframe. The bill requires that payments be resolved within 45 days and protects government officials from personal liability if they act in good faith to stop suspicious transactions. Additionally, it allows for the exemption of routine, historically consistent payment amounts while investigating anomalous or unusually large portions of a transfer.

Maddy summaryThis bill establishes new pre-payment verification requirements for federal agencies to prevent fraud before any money is disbursed. It mandates that agencies confirm a payee's identity, bank account validity, and eligibility using a centralized "Do Not Pay" system that cross-references data from the Treasury, IRS, and Social Security Administration. Additionally, the legislation requires recipients of federal awards over $50,000 to submit a one-time report detailing how they intend to use the funds within 180 days of receiving them. The act also expands the types of sensitive data the Treasury can access to detect improper payments while including specific privacy protections and penalties for unauthorized disclosure.

Maddy summaryHR 3490, the Gerald E. Connolly Esophageal Cancer Awareness Act of 2025, requires the Government Accountability Office (GAO) to study federal health benefits coverage for esophageal cancer. Specifically, the GAO must report on healthcare spending for federal employees and retirees diagnosed with esophageal cancer and how often high-risk individuals under this program undergo recommended screenings. The bill targets federal employees and retirees covered by the Federal Employees Health Benefits Program who meet specific risk factors (such as age 50+, smoking history, or GERD). It does not create new programs but mandates a study to assess current screening practices and costs. The goal is to inform future policy based on data about screening adherence and healthcare impacts.

Maddy summaryHR 1041, the Veterans 2nd Amendment Protection Act, prevents the Department of Veterans Affairs (VA) from automatically sending veterans' personal information to the national background check system (NICS) solely because a court has appointed a fiduciary (like a guardian) to manage their benefits. This directly affects veterans who have a fiduciary appointed due to mental health or cognitive challenges but are not deemed a danger to themselves or others. The bill requires a court order finding the veteran poses a danger before any such information can be shared with the NICS. It changes VA procedures to block unnecessary barriers to firearm ownership for veterans who qualify for fiduciary support without a judicial determination of danger.

Maddy summaryThe Recycling Infrastructure and Accessibility Act of 2025 establishes a competitive federal grant program to fund projects improving recycling access in underserved communities. It authorizes $30 million annually (2025-2029) for grants to states, local governments, tribes, or public-private partnerships to build infrastructure like transfer stations, expand curbside collection, or reduce transport costs. Grants must be $500,000-$15 million, with 70% reserved for projects in communities lacking a materials recovery facility within 75 miles. The program requires grantees to report on implementation and outcomes, excluding funding for recycling education.

Hemp Planting Predictability Act This bill extends by two years the implementation of changes to the regulation of hemp products, which reimpose certain federal controls over some hemp products. Specifically, Congress enacted the FY2026 agriculture appropriations act (P.L. 119-37) on November 12, 2025. Effective November 12, 2026, the act modifies the statutory definition of hemp products that are considered to be lawful. This bill extends the effective date to November 12, 2028. As background, the 2018 farm bill excluded hemp from the Controlled Substances Act definition of marijuana and defined hemp . As a result, hemp and hemp-derived products at or below the 0.3% delta-9 tetrahydrocannabinol (THC, the psychoactive component of marijuana) concentration threshold were no longer regulated as Schedule I controlled substances and registration with the Drug Enforcement Administration was no longer required to cultivate or handle hemp and hemp-derived products. However, hemp remained subject to Department of Agriculture and Food and Drug Administration regulation. The 2025 changes to the definition of hemp, include changing the limit to a total THC concentration of not more than 0.3% on a dry weight basis rather than only delta-9 THC, explicitly including industrial hemp, excluding seeds from a cannabis plant that exceed a certain THC concentration, and excluding various types of hemp-derived cannabinoid products. Cannabinoids refer to unique chemical compounds that are found in hemp and marijuana (e.g., THC) and are known to exhibit a range of psychological and physiological effects.

This bill extends by two years the implementation of changes to the regulation of hemp products, which reimpose certain federal controls over some hemp products. Specifically, Congress enacted the FY2026 agriculture appropriations act (P.L. 119-37) on November 12, 2025. Effective November 12, 2026, the act modifies the statutory definition of hemp products that are considered to be lawful. This bill extends the effective date to November 12, 2028. As background, the 2018 farm bill excluded hemp from the Controlled Substances Act definition of marijuana and defined hemp . As a result, hemp and hemp-derived products at or below the 0.3% delta-9 tetrahydrocannabinol (THC, the psychoactive component of marijuana) concentration threshold were no longer regulated as Schedule I controlled substances and registration with the Drug Enforcement Administration was no longer required to cultivate or handle hemp and hemp-derived products. However, hemp remained subject to Department of Agriculture and Food and Drug Administration regulation. The 2025 changes to the definition of hemp, include changing the limit to a total THC concentration of not more than 0.3% on a dry weight basis rather than only delta-9 THC, explicitly including industrial hemp, excluding seeds from a cannabis plant that exceed a certain THC concentration, and excluding various types of hemp-derived cannabinoid products. Cannabinoids refer to unique chemical compounds that are found in hemp and marijuana (e.g., THC) and are known to exhibit a range of psychological and physiological effects.